SOPHiA GENETICS director awarded RSUs and options

SOPHiA GENETICS SA director Kathy L. Hibbs received new equity awards as part of her compensation.

Rhea-AI Filing Summary

SOPHiA GENETICS SA director Kathy L. Hibbs received new equity awards as part of her compensation. She was granted 19,724 restricted stock units, each representing one ordinary share, at a reference price of $5.46 per share. Following this award, she directly holds 109,492 ordinary shares.

She also received options to buy 28,818 ordinary shares at an exercise price of $5.46 per share, expiring on June 18, 2036, bringing her total option holdings to 218,569 share options. Both the RSUs and options were granted on June 18, 2026 and vest 100% at the date of the company’s next scheduled annual meeting of shareholders, subject to her continued service.

Insider Trade Summary

Grant/Award: 48,542 shares

Grant/Award 2 txns

Insider HIBBS KATHY L

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Share Option (Right to Buy)	28,818	$5.46	$157K
Grant/Award	Ordinary Shares	19,724	$5.46	$108K

Holdings After Transaction: Share Option (Right to Buy) — 218,569 contracts (Direct); Ordinary Shares — 109,492 shares (Direct)

Footnotes (2)

1. F1. Represents a restricted stock unit ("RSU") grant. Each RSU represents a contingent right to receive one ordinary share of the Issuer, subject to Reporting Person's continued service with the Issuer. The RSUs were granted on June 18, 2026 and vest 100% as of the date of the Issuer's next scheduled annual meeting of shareholders.
2. F2. The share options were granted on June 18, 2026 and vest 100% as of the date of the Issuer's next scheduled annual meeting of shareholders, subject to the Reporting Person's continued service to the Issuer through the relevant vesting date.

Key Figures

RSU grant: 19,724 units Option grant: 28,818 options Option exercise price: $5.46 per share +3 more

6 metrics

RSU grant 19,724 units Restricted stock units granted June 18, 2026

Option grant 28,818 options Share options granted June 18, 2026

Option exercise price $5.46 per share Exercise price for new share options

Shares held after grant 109,492 shares Ordinary shares directly held after RSU award

Options held after grant 218,569 options Total share options following June 18, 2026 grant

Option expiration June 18, 2036 Expiration date of new share options

Key Terms

restricted stock unit ("RSU"), Share Option (Right to Buy), vest 100%, annual meeting of shareholders, +1 more

5 terms

restricted stock unit ("RSU") financial

"Represents a restricted stock unit ("RSU") grant. Each RSU represents a contingent right to receive one ordinary share"

Share Option (Right to Buy) financial

"security_title: "Share Option (Right to Buy)""

vest 100% financial

"vest 100% as of the date of the Issuer's next scheduled annual meeting of shareholders"

annual meeting of shareholders financial

"as of the date of the Issuer's next scheduled annual meeting of shareholders"

A yearly gathering where a company’s owners (shareholders) vote on key items like electing the board, approving executive pay, and ratifying auditors, and receive updates on performance and strategy. Think of it as an annual town hall for owners: it matters to investors because outcomes and disclosures can affect leadership, corporate direction, dividend and governance policies, and therefore the company’s risk and potential return.

exercise price financial

"The share options were granted on June 18, 2026 and vest 100% ... with a conversion or exercise price of 5.4600"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity awards did SOPH director Kathy Hibbs receive in this Form 4?

Kathy L. Hibbs received 19,724 restricted stock units and options on 28,818 ordinary shares. Both awards were granted on June 18, 2026 as part of her compensation, tied to SOPHiA GENETICS SA ordinary shares.

At what price can the new SOPH share options granted to Kathy Hibbs be exercised?

The new share options have an exercise price of $5.46 per share. This means Hibbs can buy ordinary shares at $5.46 once the options vest, regardless of the market price at that time.

When do Kathy Hibbs’ new SOPH RSUs and options vest?

Both the RSUs and options vest 100% on the date of SOPHiA GENETICS SA’s next scheduled annual meeting of shareholders. Vesting is conditional on her continued service with the company through that meeting date.

How many SOPH ordinary shares does Kathy Hibbs hold after these grants?

After the RSU grant, Hibbs directly holds 109,492 ordinary shares. This figure reflects her updated direct ownership position reported in the Form 4 following the June 18, 2026 equity awards.

What is the total SOPH option position reported for Kathy Hibbs after this filing?

Following the new grant of 28,818 options, Hibbs is reported as holding 218,569 share options in total. All these options relate to SOPHiA GENETICS SA ordinary shares and have specified exercise terms and an expiration date.

Are the SOPH equity transactions by Kathy Hibbs open-market buys or compensation grants?

These transactions are compensation-related grants, not open-market purchases. The Form 4 classifies them as awards (code A), covering RSUs and share options granted by SOPHiA GENETICS SA subject to future vesting conditions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/22/2026 - 04:01 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HIBBS KATHY L

(Last) (First) (Middle)

C/O SOPHIA GENETICS INC.

401 PARK, 5TH FLOOR

(Street)

BOSTON MASSACHUSETTS 02215

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
SOPHiA GENETICS SA [ SOPH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	06/18/2026		A		19,724(1)	A	$5.46	109,492	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Share Option (Right to Buy)	$5.46	06/18/2026		A		28,818		(2)	06/18/2036	Ordinary Shares	28,818	$5.46	218,569	D

Explanation of Responses:

1. Represents a restricted stock unit ("RSU") grant. Each RSU represents a contingent right to receive one ordinary share of the Issuer, subject to Reporting Person's continued service with the Issuer. The RSUs were granted on June 18, 2026 and vest 100% as of the date of the Issuer's next scheduled annual meeting of shareholders.

2. The share options were granted on June 18, 2026 and vest 100% as of the date of the Issuer's next scheduled annual meeting of shareholders, subject to the Reporting Person's continued service to the Issuer through the relevant vesting date.

Remarks:

	/s/ Elimara Brunetto as Attorney-in-Fact for Kathy L. Hibbs	06/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)